◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

BIOCLINICA INC

BIOCLINICA INC
None CIK: 822418 Services
NEWTOWN, PA
Loading...
Price History
Market Data
Market Cap-
P/E Ratio-
P/B Ratio-
EPS-
Dividend Yield-
D/E Ratio0.62
Current Ratio1.50
CurrencyUSD
Key Financial Metrics
98.28M
Revenue
3.73M
Net Income
-
EPS (Diluted)
9.20M
Free Cash Flow
Profitability
Gross Margin 50.5%
Operating Margin 6.6%
Net Profit Margin 3.8%
EBITDA 15.39M
Returns & Efficiency
Return on Assets (ROA) 3.7%
Return on Equity (ROE) 6.0%
Dividend Yield -
EPS -
Financial Health
Total Assets 101.01M
Total Debt -
Debt to Equity 0.62x
Current Ratio 1.50
Insider Trading Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report

Loading...

10-Q
Quarterly Report

Loading...

8-K
Recent News

Loading...

Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
HQNEWTOWN, PA
Fiscal Year2012
Peers
14.31B
P/E: 42.6
14.31B
P/E: 42.6
933.35M
P/E: --
46.72M
P/E: 0.4
3.76M
P/E: 0.0
3.76M
P/E: 0.0
3.25M
P/E: --
3.25M
P/E: --
Financial Statistics
Valuation
Market Cap-
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin50.5%
Operating Margin6.6%
Net Margin3.8%
ROE6.0%
ROA3.7%
Leverage & Liquidity
Debt to Equity0.62
Current Ratio1.50
Total Debt-
Total Assets$101.01M
Stockholders' Equity$62.46M
Income Statement (FY 2012)
Revenue$98.28M
Gross Profit$49.64M
Operating Income$6.51M
Net Income$3.73M
EPS (Diluted)-
Cash Flow (FY 2012)
Free Cash Flow$9.20M
Cash & Equivalents$13.91M
Revenue Growth17.0%
SEC Filings by Category
Insider Trading Activity
Neutral 0 Buys $0 0 Sales $0 0 Exercises $0 Net: $0
InsiderTitleDateTypeSharesPriceValue
Company Information
Business Address826 NEWTOWN-YARDLEY ROAD
NEWTOWN, PA 18940-1721
Phone2677573000
IncorporatedDE, US
EIN112872047
Fiscal Year End1231
Shares Outstanding15.66M
Stockholders' Equity$62.46M
Cash & Equivalents$13.91M
Recent Filings View All
15-12G Deregistration (12g)
Certification of termination of registration under 12(g)
Filed: 2013-03-29
EFFECT Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
EFFECT Effectiveness Notice
Notice of effectiveness
Filed: 2013-03-28
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
S-8 POS Employee Plan Post-Effective
Post-effective amendment for employee plan
Filed: 2013-03-22
POS AM Post-Effective Amendment
Post-effective amendment to registration statement
Filed: 2013-03-22
POS AM Post-Effective Amendment
Post-effective amendment to registration statement
Filed: 2013-03-22
Loading...

Loading management data...

Loading...

Loading board of directors...

Loading...

Loading institutional holders...

Loading...

Loading short interest data...

Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
Company NameBIOCLINICA INC
TickerNone
Exchange--
SectorServices
Industry--
HeadquartersNEWTOWN, PA
Fiscal Year2012
Financial Summary
Market Cap-
Revenue98.28M
Net Income3.73M
P/E Ratio-
EPS-
Net Margin3.8%
ROE6.0%
Dividend Yield-
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...